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ABSTRACT
N-(2-methoxyphenyl)hydroxylamine is a human metabolite of the industrial and environmental pollutants and bladder carcinogens 
2-methoxyaniline (o-anisidine) and 2-methoxynitrobenzene (o-nitroanisole). Here, we investigated the ability of hepatic microsomes 
from rat and rabbit to metabolize this reactive compound. We found that N-(2-methoxyphenyl)hydroxylamine is metabolized by 
microsomes of both species mainly to o-aminophenol and a parent carcinogen, o-anisidine, whereas 2-methoxynitrosobenzene 
(o-nitrosoanisole) is formed as a minor metabolite. Another N-(2-methoxyphenyl)hydroxylamine metabolite, the exact structure of 
which has not been identified as yet, was generated by hepatic microsomes of rabbits, but its formation by those of rats was negli-
gible. To evaluate the role of rat hepatic microsomal cytochromes P450 (CYP) in N-(2-methoxyphenyl)hydroxylamine metabolism, we 
investigated the modulation of its metabolism by specific inducers of these enzymes. The results of this study show that rat hepatic 
CYPs of a 1A subfamily and, to a lesser extent those of a 2B subfamily, catalyze N-(2-methoxyphenyl)hydroxylamine conversion to 
form both its reductive metabolite, o-anisidine, and o-aminophenol. CYP2E1 is the most efficient enzyme catalyzing conversion of 
N-(2-methoxyphenyl)hydroxylamine to o-aminophenol. 
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1978; IARC, 1982). o-Anisidine is used as an intermediate 
in the manufacturing of a number of azo and naphthol 
pigments and dyes, which are used for printing (90%) and 
for paper (3%) and textile (7%) dyeing (NTP, 1978; Garner 
et al., 1984). Such a wide use of this aromatic amine could 
result in occupational exposure. Furthermore, it may be 
released from textiles and leather goods colored with these 
azo dyes and a large part of the population may be exposed. 
This carcinogen is also a constituent of cigarette smoke 
(IARC, 1982; Stabbert et al., 2003). This strongly suggests 
that o-anisidine ranks not only among occupational pollut-
ants produced in the manufacturing of chemicals, but also 
among environmental pollutants; it can be assumed that 
human exposure is widespread. Indeed, o-anisidine was 
found in human urine samples in the general population, 
in concentrations of 0.22 µg/l (median) (Weiss and Angerer, 
2003). In addition, hemoglobin adducts of o-anisidine were 
detected in blood samples of persons living in urban or rural 
Introduction
2-Methoxyaniline  (o-anisidine)  is  a  potent  carcinogen, 
causing tumors of the urinary bladder in both genders of 
F344 rats and B6C3F1 mice (NTP, 1978; IARC, 1982). The 
International Agency for Research on Cancer (IARC) has 
classified  o-anisidine  as  a  group  2B  carcinogen  (IARC, 
1982), which is possibly carcinogenic to humans. Besides 
its carcinogenicity it exhibits other toxic effects, including 
hematological changes, anemia and nephrotoxicity (NTP, 
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areas of Germany (Falter et al., 1994; Branner et al., 1998; 
Richter et al., 2001). The adducts as well as o-anisidine in 
urine might originate not only from the sources mentioned 
above,  but  also  from  a  possible  o-anisidine  precursor, 
2-methoxynitrobenzene (o-nitroanisole). This chemical was 
released into the environment in the course of an accident 
in a German chemical plant, causing subsequently local 
and regional contamination (Falter et al., 1994; Hauthal, 
1993; Traupe et al., 1997). o-Nitroanisole exhibits strong 
carcinogenic activity, causing neoplastic transformation 
in the urinary bladder, and to a lesser extent, in the spleen, 
liver and kidneys in rodents (NTP 1993). It is also a toxic 
compound, causing anemia. The anemia is characterized by 
increased levels of methemoglobin and accelerated destruc-
tion of erythrocytes (NTP 1993). 
Recently, we have found that o-anisidine is oxidatively 
activated by peroxidase and cytochrome P450 (CYP) to spe-
cies binding to DNA in vitro (Stiborová et al., 2001; 2002; 
2005; Rýdlová et al., 2005; Naiman et al., 2008). We also dem-
onstrated that o-anisidine forms DNA adducts in vivo. The 
same adducts as found in DNA incubated with o-anisidine 
and human microsomes in vitro were detected in urinary 
bladder, the target organ, and to a lesser extent, in liver, kid-
ney and spleen of rats treated with o-anisidine (Stiborová et 
al., 2005). The o-anisidine-derived DNA adducts were iden-
tified as deoxyguanosine adducts formed from a metabolite 
of o-anisidine, N-(2-methoxyphenyl)hydroxylamine, which 
is generated by oxidation of o-anisidine with human, rabbit 
and rat hepatic microsomes (Stiborová et al., 2005; Rýdlová 
et al., 2005; Naiman et al., 2008). The same deoxyguanosine 
adducts were also detected in DNA of the urinary bladder, 
kidney, liver and spleen of rats treated with o-nitroanisole 
(Stiborová et al., 2004), an oxidized counterpart of o-anisi-
dine, and in DNA incubated with o-nitroanisole in vitro with 
human and rat hepatic cytosolic enzymes and xanthine oxi-
dase (Stiborová et al., 1998; 2004). These enzymatic systems 
were found to produce N-(2-methoxyphenyl)hydroxylamine 
after  o-nitroanisole  reduction  (Mikšanová  et  al.,  2004). 
The data indicate that formation of N-(2-methoxyphenyl)
hydroxylamine, the reactive metabolite of both carcinogens, 
is critical for generation of DNA lesions in target organs. 
Therefore, it is clear that N-(2-methoxyphenyl)hydroxyl-
amine formation and its further conversion, as well as the 
enzymes participating in such processes, play a key role in 
carcinogenic effects of both carcinogens. 
Recently, we have found that o-anisidine is oxidized by 
human, rat and rabbit hepatic microsomes not only to N-(2-
methoxyphenyl)hydroxylamine, but that this compound 
is a subject of complex redox cycling reactions, forming 
also o-aminophenol, o-nitrosoanisole and one additional 
metabolite,  the  exact  structure  of  which  has  not  been 
identified as yet (Stiborová et al., 2005; Naiman et al., 2008). 
N-(2-methoxyphenyl)hydroxylamine might also be a subject 
of complex reactions, and its fate is dependent on the envi-
ronment, in which it occurs. It can be further metabolized 
to o-aminophenol, o-nitrosoanisole and parental o-anisidine 
(Naiman et al., 2008), or when nucleophiles such as DNA or 
proteins are present in the cell, form the adducts (Stiborová 
et al., 2005) (Figure 1). 
The results of our former studies (Stiborová et al., 2005; 
Naiman et al., 2008) show a similarity among hepatic micro-
somal CYP systems metabolizing o-anisidine in humans and 
two animal models, rats and rabbits, which are the species, in 
which this agent is carcinogenic or toxic (NTP, 1978; IARC, 
1982). These findings indicate that both experimental ani-
mal species might serve as suitable models to mimic the fate 
of this carcinogen in human. However, whereas formation 
of DNA adducts by N-(2-methoxyphenyl)hydroxylamine, 
generated in reactions catalyzed with human and rat hepatic 
microsomes, has been clearly proven (Stiborová et al., 2005), 
conversion of this metabolite to further products has been 
investigated using only rabbit hepatic microsomes (Naiman 
et al., 2008). Therefore, the aim of the present study was to 
evaluate the efficiency of N-(2-methoxyphenyl)hydroxyl-
amine metabolism by hepatic microsomes from rats. 
Materials and methods
Chemicals
Chemicals  were  obtained  from  the  following  sources: 
β-naphthoflavone (β-NF), NADP+, NADPH, glucose 6-phos-
phate and bicinchoninic acid (2,2’-biquinoline-4,4’-dicar-
boxylic acid) from Sigma Chemical Co. (St. Louis, MO, USA); 
o-anisidine, o-aminophenol (>99% based on HPLC) from 
Fluka Chemie AG (Buchs, Switzerland) and glucose 6-phos-
phate dehydrogenase from Serva (Heidelberg, Germany). All 
these and other chemicals were of analytical purity or better. 
2-Methoxynitrosobenzene was synthesized in analogy to 
the synthesis described earlier (Seidenfaden, 1971) by oxida-
tion of N-(2-methoxyphenyl)hydroxylamine with potassium 
dichromate in water and identified by 1H NMR recorded on 
a 400 MHz instrument in CDCl3 (referenced to TMS): 7.68 
(1H, m), 7.36 (1H, m), 6.86 (1H, m), 6.30 (1H, m) and 4.28 (3H, 
s). N-(2-methoxyphenyl)hydroxylamine was synthesized by 
the procedure similar to that described earlier (Balaban et 
al., 1998). N-(2-Methoxyphenyl)hydroxylamine authenticity 
was confirmed by electrospray mass and CID spectra and 
high field proton NMR spectroscopy. The positive-ion elec-
trospray mass-spectrum exhibited the protonated molecule 
at m/z 140.1, while the CID of its ion fragments at m/z 125.2, 
108.1 and 109.1. The 1H-NMR spectra were recorded at 400 
MHz in dimethyl sulfoxide-d6. The central line of dimethyl 
sulfoxide at 2.500 ppm was used as reference line. The spec-
tra showed the presence of the following protons: 8.28 (1H, d,   
J = 2.3 Hz, exchanged with CD3OD), 7.64 (1H, d, J = 1.5 Hz, 
exchanged with CD3OD), 7.01 (1H, m, Σ J = 9.6 Hz), 6.84 (2H, 
m, Σ J = 15.0 Hz), 6.75 (1H, m, Σ J = 16.9 Hz), 3.75 (3H, s). 
o-Aminophenol authenticity was confirmed by ESI mass 
spectra and 1H and 13C NMR spectroscopy. The positive-ion 
mass-spectrum exhibited the protonated molecule at m/z 
110.4, while the negative-ion mass-spectrum the molecule 
at m/z 108.4. The NMR spectra were recorded on a Bruker 
Avance II-500 instrument (499.8 MHz for  1H and 125.7 
MHz for 13C) in dimethyl sulfoxide-d6 and referenced to 
the solvent signal (δ 2.50 and 39.70, respectively). 1H NMR 
spectrum showed the presence of the following signals: 8.96 
(1H, bs), 6.65 (1H, m), 6.59 (1H, m), 6.54 (1H, m), 6.40 (1H, 220
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m) and 4.46 (2H, bs). 13C NMR spectrum showed the pres-
ence of six signals of aromatic carbons: 144.26 (s), 136.78 (s), 
119.80 (d), 116.75 (d), 114.73 (d) and 114.64 (d).
Animal experiments, preparation of microsomes and assays 
The  study  was  conducted  in  accordance  with  the 
Regulations for the Care and Use of Laboratory Animals 
(311/1997, Ministry of Agriculture, Czech Republic), which 
complies with Declaration of Helsinki. Microsomes from 
livers of ten untreated rats and three rabbits were prepared 
by the procedure described previously (Stiborová et al., 
1988). Microsomes from the livers of ten male Wistar rats 
pretreated with β-NF (Stiborová et al., 1988) were isolated 
as described (Stiborová et al., 1988; 1995), those pretreated 
with phenobarbital (PB) as reported by Hodek et al. (1988), 
and those pretreated with ethanol were isolated using a 
procedure described by Yang et al. (1985). Protein concen-
trations in the microsomal fractions were assessed using the 
bicinchoninic acid protein assay with bovine serum albumin 
as a standard (Wiechelman et al., 1988). The concentration 
of CYP was estimated according to Omura and Sato (1964), 
by measuring the absorption of the complex of reduced CYP 
with carbon monoxide. Rat and rabbit liver microsomes 
contained 0.6 and 1.8 nmol CYP/mg protein, respectively. 
Hepatic microsomes of rats induced with β-NF, PB, and 
ethanol contained 1.3, 2.7 and 1.8 nmol CYP/mg protein, 
respectively. The activity of NADPH:CYP reductase in rat 
hepatic microsomes was measured according to Sottocasa 
et  al.  (1967)  using  cytochrome  c  as  substrate  (i.e.,  as 
NADPH:cytochrome c reductase). NADPH:CYP reductase 
activities in hepatic microsomes of control (uninduced) rats 
and those induced with β-NF, PB and ethanol were 0.210, 
0.199, 0.325 and 0.201 µmol/min/mg protein, respectively. 
Incubations 
Incubation  mixtures  used  for  study  of  the  o-anisidine 
metabolism contained the following concentrations in a 
final volume of 100 µl: 100 mM sodium phosphate buffer 
(pH 7.4),  1 mM  NADP+,  10 mM  D-glucose  6-phosphate, 
1 U/ml D-glucose 6-phosphate dehydrogenase (NADPH-
generation  system),  a  rat  or  rabbit  hepatic  microsomal 
fraction containing 0.04–1.0 nmol CYP, and 0.1–2.0 mM 
o-anisidine dissolved in 1.0 µl methanol. The reaction was 
initiated by adding the substrate. To study metabolism of 
N-(2-methoxyphenyl)hydroxylamine, incubation mixtures 
contained the following concentrations in a final volume 
of 100 µl: 100 mM sodium phosphate buffer (pH 7.4), 1 mM 
NADP+, 10 mM D-glucose 6-phosphate, 1 U/ml D-glucose 
6-phosphate dehydrogenase (NADPH-generation system), 
a rat and rabbit hepatic microsomal fraction containing 
0.04–1.0 nmol CYP, and 0.1–1.0 mM N-(2-methoxyphenyl)
hydroxylamine dissolved in 1.0 µl distilled water. The reac-
tion was initiated by adding the substrate. After incubation 
in  open  glass  tubes  (37oC,  30  min),  the  reactions  were 
terminated by adding 100 µl of methanol and centrifuged 
at 5,000 g for 5 min. Metabolism of o-anisidine and N-(2-
methoxyphenyl)hydroxylamine with rat and rabbit CYP 
enzymatic systems was linear until 40 min. The super-
natants were collected and 20 µl aliquots applied onto a 
high-performance liquid chromatography (HPLC) column, 
where metabolites of o-anisidine were separated. The HPLC 
was performed on a C-18 reversed-phase column (250 × 
4.6 mm, 5 µm, Nucleosil 100-5, Macherey-Nagel, Duren, 
Germany). Metabolites were eluted with 18% methanol, 
82% 7.18 µM aqueous ammonia, pH 8.0, (v/v) at a flow rate 
of 0.6 ml/min and monitored at 254 nm. o-Anisidine and 
N-(2-methoxyphenyl)hydroxylamine metabolites were ana-
lyzed by mass spectrometry and by comparing their chro-
matographic properties on HPLC with those of synthetic 
standards.  2-Methoxynitrosobenzene,  o-aminophenol, 
N-(2-methoxyphenyl)hydroxylamine and 2-methoxynitro-
benzene standards, were eluted at retention times (r.t.) of 
8.8, 11.3, 19.7 and 57.5 min, respectively (Stiborová et al., 
2005; Naiman et al., 2008). 
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Figure 1. Pathways of o-anisidine metabolism by the cytochrome 
P450 system showing the characterized metabolites and those 
proposed to form DNA adducts. The compounds shown in brack-
ets were not detected under the experimental conditions.221
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Results 
Metabolism of N-(2-methoxyphenyl)hydroxylamine 
by rat and rabbit hepatic microsomes 
When  a  parental  compound  from  which  N-(2-
methoxyphenyl)hydroxylamine is generated, o-anisidine, 
was incubated with rat and rabbit hepatic microsomes in 
the presence of NADPH, two metabolites, o-aminophenol 
(r.t. of 11.3 min) and N-(2-methoxyphenyl)hydroxylamine 
(r.t. of 19.7 min), as well as an additional product peak of 
metabolite 1 (M1, r.t. of 7.0 min), which structure has not 
been identified as yet, were separated by HPLC (see peaks in 
Figure 2A for the profile obtained with rabbit microsomes) 
(Naiman et al., 2008).. 
The results of experiments with N-(2-methoxyphenyl)
hydroxylamine and microsomes demonstrated that metab-
olites M1 and o-aminophenol are also formed from this 
o-anisidine metabolite by rabbit hepatic microsomes (Figure 
2B), while formation of the metabolite M1 from this com-
pound by hepatic microsomes of rats was negligible (Figure 
2C).  When  N-(2-methoxyphenyl)hydroxylamine  was 
incubated without hepatic microsomal enzymes or without 
NADPH, metabolite M1 and o-aminophenol peaks were 
also detectable by HPLC, but only under acidic conditions 
(pH 4.5 for 60 min). At pH 7.4, used for microsomal incu-
bations, their spontaneous formation was negligible. This 
finding indicates that conversion of N-(2-methoxyphenyl)
hydroxylamine in microsomes is mediated by enzymatic 
reactions.  During  metabolism  of  N-(2-methoxyphenyl)
hydroxylamine  by  hepatic  microsomes  of  both  species, 
a shoulder at 8.8 min was also detectable (Figure 2B,C), 
suggesting formation of o-nitrosoanisole (2-methoxynitro-
sobenzene) (r.t. of 8.8 min, Figure 2F). Moreover, during the 
incubations of N-(2-methoxyphenyl)hydroxylamine with rat 
and rabbit microsomes and NADPH, an additional product 
peak was detected by HPLC, being identified to be the paren-
tal compound, o-anisidine (r.t. of 28.6 min) (Figure 2B,C). 
Involvement of CYP enzymes in N-(2-methoxyphenyl)
hydroxylamine metabolism in rat hepatic microsomes 
In order to evaluate the participation of individual rat hepatic 
microsomal CYPs in N-(2-methoxyphenyl)hydroxylamine 
metabolism, the induction of individual CYP enzymes was 
performed with this animal model. Microsomes isolated 
from livers of uninduced rats and rats pre-treated with β-NF 
(enriched with CYP1A1/2), PB (enriched with CYP2B1/2) 
and ethanol (enriched with CYP2E1) were used (Table 1). 
Except of the enzymes present in microsomes of liv-
ers of rats pre-treated with ethanol, the enzymes of all 
other microsomes tested in this study formed from N-(2-
methoxyphenyl)hydroxylamine predominantly its reductive 
metabolite, o-anisidine. More than 2-fold higher levels of 
o-anisidine than o-aminophenol were determined when 
N-(2-methoxyphenyl)hydroxylamine was incubated with 
these microsomes and NADPH (Table 1). Levels of the 
N-(2-methoxyphenyl)hydroxylamine reductive metabolite, 
o-anisidine, did not correspond to activities of NADPH:CYP 
reductase in individual microsomes. Namely, activities of 
this enzyme in hepatic microsomes of control (uninduced) 
rats and those induced with β-NF, PB and ethanol used in 
the experiments are similar, being 0.210, 0.199, 0.325 and 
0.201 µmol/min/mg protein, respectively. While incuba-
tions of N-(2-methoxyphenyl)hydroxylamine with hepatic 
microsomes of rats pre-treated with β-NF led to a 2.4- and 
1.9-fold increase (P<0.05) in o-aminophenol and o-anisidine 
formation, respectively (Table 1), another inducer of CYP 
enzymes, PB, had much less effect. Even though a 1.4- and 
1.2-fold increase in o-aminophenol and o-anisidine for-
mation, respectively, was mediated by treating rats with 
this CYP inducer (Table 1), this increase was statistically 
insignificant. Ethanol, an inducer of CYP2E1, stimulated 
production of o-aminophenol from N-(2-methoxyphenyl)
hydroxylamine,  by  3-fold  (P<0.05),  whereas  decreased 
levels of the N-(2-methoxyphenyl)hydroxylamine reduc-
tion metabolite, o-anisidine. These results indicate that rat 
hepatic CYP2E1, CYPs of a 1A subfamily and, to a lesser 
extent, those of a 2B subfamily, are capable of metabolizing 
N-(2-methoxyphenyl)hydroxylamine in rat livers. 
It should be noted that the results of experiments with 
inducers  should  be  carefully  interpreted,  because  these 
inducers are not absolutely specific for individual CYPs. 
Therefore,  to  confirm  the  role  of  these  CYPs  in  N-(2-
methoxyphenyl)hydroxylamine  metabolism,  additional 
experimental approaches such as selective inhibition of 
CYPs and utilization of the purified CYP reconstituted 
with NADPH: CYP reductase are planned to be employed 
in further studies. 
Discussion
The results of this study show that rat and rabbit hepatic 
microsomes can metabolize N-(2-methoxyphenyl)hydroxyl-
amine, a reactive metabolite of carcinogenic o-anisidine and 
o-nitroanisole. This compound is responsible for genotoxic 
effects of both carcinogens, because it is easily decomposed 
to  the  nitrenium/carbenium  ion  forming  DNA  adducts 
(Figure 1) (Stiborová et al., 2004; 2005; Naiman et al., 2008). 
The results demonstrate that N-(2-methoxyphenyl)hydrox-
ylamine  is  also  further  metabolized  to  o-aminophenol, 
o-nitrosoanisole and the parent compound, o-anisidine. The 
table 1. 
Metabolism of N-(2-methoxyphenyl)hydroxylamine in rat hepatic micro-
somes induced with different agents
Hepatic microsomes
N-(2-methoxyphenyl)hydrox-
ylamine metabolites a 
from rats pretreated with b o-aminophenol o-anisidine
None - control microsomes  2.0 ± 1.0 5.8 ± 0.7
β-naphthoflavone (CYP1A1/2) 4.8 ± 1.7 11.1 ± 3.3
Phenobarbital (CYP2B1/2) 2.8 ± 2.5 7.0 ± 2.0
Ethanol (CYP2E1) 6.1 ± 3.1 3.5 ± 0.7
a The numbers are the peak area/min/nmol CYP for each metabolite; 
averages ± S.E.M of three determinations in separate experiments.
b Isoforms of CYP induced are shown in brackets.222
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Figure 2. HPLC elution profiles of metabolites of 1 mM o-anisidine incubated with rabbit microsomes (a), of 1.0 mM N-(2-methoxyphenyl)
hydroxylamine incubated with rabbit (b) and rat (c) hepatic microsomes. (D) synthetic N-(2-methoxyphenyl)hydroxylamine and o-anisidine. (e) 
o-aminophenol. (F) o-nitrosoanisole. For incubation conditions see Materials and methods. Peaks eluting between 2.0 and 5.5 min, solvent front, 
NADPH and protein components of microsomes and NADPH-generation system.223
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formed o-anisidine may be O-demethylated again to o-ami-
nophenol (Figure 1). The question whether o-aminophenol 
is also formed from N-(2-methoxyphenyl)hydroxylamine by 
its O-demethylation to N-(2-hydroxyphenyl)hydroxylamine, 
which is subsequently reduced to o-aminophenol (Figure 
1), remains to be answered. No metabolites formed by this 
reaction were observed. 
Recently, redox cycling reactions similar to those we 
found  with  N-(2-methoxyphenyl)hydroxylamine  were 
observed  by  Kim  et  al.  (2004),  who  studied  metabo-
lism  of  several  aromatic  and  heterocyclic  amines  by  a 
CYP1A2/NADPH:CYP reductase enzymatic system. They 
reported that the CYP system catalyzes oxidation of the 
N-hydroxylated intermediate formed from the carcinogenic 
heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quino-
line (IQ), to a nitrosoderivative. They demonstrated that 
NADPH:CYP reductase can catalyze the reduction of the 
IQ oxidation products, N-nitroso-IQ and N-hydroxyl-IQ, to 
N-hydroxyl-IQ and the parent amine, IQ (Kim et al., 2004). 
N-hydroxylation products of two other aromatic amines 
investigated by Kim et al. (2004), 2-aminofluorene and 
4-aminobiphenyl, are, however, reduced non-enzymatically, 
by NADPH. We have not determined whether reduction 
of  N-(2-methoxyphenyl)hydroxylamine  to  o-anisidine 
requires  catalysis  by  NADPH:CYP  reductase  or  occurs 
non-enzymatically,  or  is  mediated  by  other  enzymes. 
However,  preliminary  experiments  performed  in  our 
laboratory suggest that although NADPH:CYP reductase 
might  partially  participate  in  N-(2-methoxyphenyl)
hydroxylamine  reduction  to  o-anisidine,  CYP  enzymes 
present in hepatic microsomes are more effective in this 
process. (Naiman et al., unpublished results). Indeed, the 
results of the present study demonstrate that rat hepatic 
microsomes reduce N-(2-methoxyphenyl)hydroxylamine 
to o-anisidine independently on activities of NADPH:CYP 
reductase. The present study shed also some light on the 
role of specific microsomal CYP enzymes in metabolism of 
N-(2-methoxyphenyl)hydroxylamine. The CYP1A enzymes 
seem to be most efficient in N-(2-methoxyphenyl)hydrox-
ylamine  reduction.  Nevertheless,  the  question  whether 
CYP2E1 is also effective in reducing N-(2-methoxyphenyl)
hydroxylamine, remains to be answered. Among hepatic 
microsomes tested in this study, those of rats treated with 
ethanol (enriched with CYP2E1) produced the lowest levels 
of o-anisidine from N-(2-methoxyphenyl)hydroxylamine. 
In  contrast,  o-aminophenol  was  the  major  metabolite 
in microsomes enriched with CYP2E1, generated at the 
highest  levels  among  the  microsomes  employed  in  the 
experiments. These findings suggest that CYP2E1 is not 
effective in N-(2-methoxyphenyl)hydroxylamine reduction. 
Nevertheless, because CYP2E1 is the most effective CYP 
enzyme oxidizing o-anisidine to o-aminophenol (Stiborová 
et al., 2005; Naiman et al., 2008), one can speculate that 
this enzyme efficiently utilizes o-anisidine, which could 
be generated in this microsomal system, oxidizing it to 
o-aminophenol. Therefore, the participation of CYP2E1 
in  N-(2-methoxyphenyl)hydroxylamine  reduction  to 
o-anisidine cannot be excluded and awaits further investi-
gation. The study utilizing purified CYP2E1 reconstituted 
with NADPH:CYP reductase is planned to be performed to 
explain this question. 
While the formation of N-(2-methoxyphenyl)hydroxyl-
amine was clearly identified to be the activation pathway 
of o-anisidine and o-nitroanisole metabolism (Stiborová 
et al., 2004; 2005), biological significance of formation of 
o-aminophenol  for  detoxication/activation  metabolism 
awaits further investigation. o-Aminophenol might be con-
sidered to be mutagenic, because it induces sister chromatid 
exchanges in a dose-dependent manner in cultured human 
lymphocytes in vitro and in Chinese hamster bone marrow 
cells in vivo (Kirchner and Bayer, 1992). In addition, Brennan 
and Schiestl (1997) reported that o-aminophenol is positive 
in the deletion recombination assay in Sacchromyces cere-
visiae. Even though o-aminophenol has not been found 
to form covalent DNA adducts, it was demonstrated in 
in-vitro experiments to cause DNA damage, forming 8-oxy-
7,8-dihydro-2’-deoxyguanosine in the presence of metal 
ions such as Cu(II) (Okhuma and Kawanishi, 2001). Hence, 
due  to  such  processes,  o-aminophenol  may  contribute 
to  initiation  of  the  o-anisidine-  and/or  o-nitroanisole-
mediated carcinogenesis in the urinary bladder, and in a 
tumor development induced by other bladder carcinogenic 
aromatic amines, which produce this compound as one of 
the metabolites (Brennan and Schiestl, 1997). Furthermore, 
O-demethylation reactions produce formaldehyde (Figure 
1), which is known to modify DNA, generating several 
products including hydroxymethyl adducts and cross-links 
(Beland et al., 1984; Huang and Hopkins, 1993; Cheng et al., 
2003). Formaldehyde is mutagenic in a variety of different 
test systems and carcinogenic in laboratory animals (IARC, 
2006) and has been described as “carcinogenic to human” 
by the IARC and “reasonably anticipated to be a human 
carcinogen” by the U.S. Department of Health and Human 
Services (2004). Therefore, on the one hand, it is plausible 
that formaldehyde-DNA adducts could also play a role in 
carcinogenesis by o-anisidine. On the other hand, however, 
formaldehyde produced in the cell is also detoxified by 
conjugation to glutathione and oxidized (Dhareshwar and 
Stella, 2008); therefore, it is not likely a strong contributor 
to carcinogenicity caused by o-anisidine.
It should be noted that tumor development in a specific 
organ is influenced by promotional pressures on initiated 
cells in target organs and not only by the levels of DNA 
adducts formed by the compounds like o-anisidine and 
o-nitroanisole. It is known that radicals formed from sev-
eral carcinogens producing oxidative DNA damage, such 
as 8-hydroxy-2’-deoxyguanosine, are important not only in 
initiation, but also in promotion phases of carcinogenesis 
(Imaoka et al., 2004). Therefore, their formation from o-ami-
nophenol may be one of the factors contributing to tumor 
promotion in o-anisidine- and/or o-nitroanisole-mediated 
carcinogenesis. In addition, o-anisidine is oxidized by sev-
eral peroxidases, which are expressed in target organs (e.g. 
COX), to form radicals besides DNA adducts (Brennan, and 
Schiestl, 1999; Sasaki et al., 1998). Hence, the production of 
such free radicals in or near the target cells may be another 
factor important in the promotional process in o-anisidine-
mediated tumor development. However, the exact functions 224
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of such and/or other promotional pressures caused both by 
o-anisidine and o-aminophenol in an o-anisidine-mediated 
tumorigenesis remain to be resolved.
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